Amber L. Southwell - Concepedia

Author

Amber L. Southwell

Also Known As

A. L. Southwell, A. Southwell, A.L. Southwell, Amber L Southwell, Amber L. Southwell, Amber Lee Southwell, Amber Southwell, Amber L. Southwell, Southwell, A, Southwell, Amber

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Child and Family Research Institute California Institute of Technology Ionis Pharmaceuticals (United States)University of Central Florida

About

Amber L. Southwell is an author at University of British Columbia specializing in medicine, genetics, and neurodegeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.6K
2	Natural Sciences	3	3	233
3	Social Sciences	3	3	415
4	Health Sciences	2	2	506
5	Engineering	1	1	112

Amber L. Southwell

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Assessment of Motor Balance and Coordination in Mice using the Balance Beam Tinh N. Luong, Holly J. Carlisle, Amber L. Southwell, Journal of Visualized Experiments Neuromuscular CoordinationPaw SlipsMotor SkillMotor ControlMotor Difficulty	2011	387
Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin Jeffrey B. Carroll, Simon C. Warby, Amber L. Southwell, Molecular Therapy	2011	287
Atypical expansion in mice of the sensory neuron-specific <i>Mrg</i> G protein-coupled receptor family Mark J. Zylka, Xinzhong Dong, Amber L. Southwell, Proceedings of the National Academy of Sciences Synaptic TransmissionGeneticsMolecular PainNeurotransmissionPeripheral Nerves	2003	251
GABA Transporter Deficiency Causes Tremor, Ataxia, Nervousness, and Increased GABA-Induced Tonic Conductance in Cerebellum Chi‐Sung Chiu, Stephen G. Brickley, Kimmo Jensen, Journal of Neuroscience	2005	238
Intrabody Gene Therapy Ameliorates Motor, Cognitive, and Neuropathological Symptoms in Multiple Mouse Models of Huntington's Disease Amber L. Southwell, Jan Ko, Paul H. Patterson Journal of Neuroscience	2009	227
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS Michael E. Østergaard, Amber L. Southwell, Holly Kordasiewicz, Nucleic Acids Research	2013	158
In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides Amber L. Southwell, Niels H. Skotte, Holly Kordasiewicz, Molecular Therapy	2014	145
Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice Mahmoud A. Pouladi, Lisa M. Stanek, Yuanyun Xie, Human Molecular Genetics Yac128 MiceMotor LearningGeneticsNeurochemical BiomarkersExperimental Neuropathology	2012	138
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes Amber L. Southwell, Amy Smith-Dijak, Chris Kay, Human Molecular Genetics NeurogenomicsGeneticsMolecular BiologyDisease Gene IdentificationSynaptic Signaling	2016	136
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease Jana Miniarikova, Ilaria Zanella, Angelina Huseinovic, Molecular Therapy — Nucleic Acids	2016	131

Page 1